FR2088145A1 - 6-hydroxy nicotinic acid derivs - with local anaesthetic activity - Google Patents

6-hydroxy nicotinic acid derivs - with local anaesthetic activity

Info

Publication number
FR2088145A1
FR2088145A1 FR7018769A FR7018769A FR2088145A1 FR 2088145 A1 FR2088145 A1 FR 2088145A1 FR 7018769 A FR7018769 A FR 7018769A FR 7018769 A FR7018769 A FR 7018769A FR 2088145 A1 FR2088145 A1 FR 2088145A1
Authority
FR
France
Prior art keywords
nicotinic acid
local anaesthetic
acid derivs
anaesthetic activity
hydroxy nicotinic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7018769A
Other languages
English (en)
French (fr)
Other versions
FR2088145B1 (cg-RX-API-DMAC10.html
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bpifrance Financement SA
Original Assignee
Agence National de Valorisation de la Recherche ANVAR
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Agence National de Valorisation de la Recherche ANVAR filed Critical Agence National de Valorisation de la Recherche ANVAR
Priority to FR7018769A priority Critical patent/FR2088145A1/fr
Publication of FR2088145A1 publication Critical patent/FR2088145A1/fr
Application granted granted Critical
Publication of FR2088145B1 publication Critical patent/FR2088145B1/fr
Granted legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/81Amides; Imides
    • C07D213/82Amides; Imides in position 3
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/79Acids; Esters
    • C07D213/80Acids; Esters in position 3

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FR7018769A 1970-05-22 1970-05-22 6-hydroxy nicotinic acid derivs - with local anaesthetic activity Granted FR2088145A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FR7018769A FR2088145A1 (en) 1970-05-22 1970-05-22 6-hydroxy nicotinic acid derivs - with local anaesthetic activity

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR7018769A FR2088145A1 (en) 1970-05-22 1970-05-22 6-hydroxy nicotinic acid derivs - with local anaesthetic activity

Publications (2)

Publication Number Publication Date
FR2088145A1 true FR2088145A1 (en) 1972-01-07
FR2088145B1 FR2088145B1 (cg-RX-API-DMAC10.html) 1973-04-06

Family

ID=9055966

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7018769A Granted FR2088145A1 (en) 1970-05-22 1970-05-22 6-hydroxy nicotinic acid derivs - with local anaesthetic activity

Country Status (1)

Country Link
FR (1) FR2088145A1 (cg-RX-API-DMAC10.html)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0405931A3 (en) * 1989-06-30 1991-09-25 Eli Lilly And Company Improvements in and relating to anticonvulsant agents

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE743467C (de) * 1938-02-28 1944-01-14 Boehringer & Soehne Gmbh Verfahren zur Herstellung von Nicotinsaeure-alkaminestern

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE743467C (de) * 1938-02-28 1944-01-14 Boehringer & Soehne Gmbh Verfahren zur Herstellung von Nicotinsaeure-alkaminestern

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0405931A3 (en) * 1989-06-30 1991-09-25 Eli Lilly And Company Improvements in and relating to anticonvulsant agents

Also Published As

Publication number Publication date
FR2088145B1 (cg-RX-API-DMAC10.html) 1973-04-06

Similar Documents

Publication Publication Date Title
GB1171156A (en) Improvements in or relating to Cycloalkane Derivatives and the Manufacture thereof
GB1373549A (en) 3-halogenopyridazines and their preparation
FR2088145A1 (en) 6-hydroxy nicotinic acid derivs - with local anaesthetic activity
ES418921A1 (es) Procedimiento para la obtencion de derivados de 2-nitroimi-dazol.
ES452986A1 (es) Procedimiento para preparar ester isobutilico de acido 2,6- dimetil-3-metoxicarbonil-4-(2'-nitrofenil)-1, 4-dihidropiri-din-5-carboxilico).
GB1387735A (en) 1,4-diazacycloalkane derivatives and their acid addition compounds
BE619713A (fr) Composé thérapeutique à base d'acide fusidique ou d'un de ses sels, et d'un dérivé d'acide 6-aminopénicillanique
ES349605A1 (es) Procedimiento para la preparacion de derivados de 5-nitrozitiazol.
GB1344853A (en) Derivative of pyridoxine alpha-ketoglutarate
ES409637A1 (es) Procedimiento para la obtencion de 1,2,3,4,10,10a-hexahi- dropirazino (1,2:a) indol-2-carboxamidinas.
GB1498126A (en) Phenoxy isobutyric acid derivatives process for their preparation and pharmaceutical compositions containing them
GB1318859A (en) Imidazo-4,5-b-pyridine derivatives
IE35420B1 (en) Amino-s-triazolylbenzenesulphonamides
GB1280754A (en) Thioamides of 4-substituted syringic acid
GB1312392A (en) Basically substituted 4 3h-quinazolinone derivatives and process for their manufacture
SE7609497L (sv) Forfarande for framstellning av 2-hydroximetyl-3-hydroxi-6-(1-hydroxi-2-t-butylaminoetyl)-pyridin och mellanprodukter derav
GB1304164A (cg-RX-API-DMAC10.html)
GB1103155A (en) Improvements in and relating to quinazolines
GB1084439A (en) Improvements in or relating to heteroeyclic compounds and the manufacture thereof
GB1070309A (en) 4-aminoquinoline derivatives
FR2386524A1 (fr) Amino-4 chloro-5 methoxy-2 n-(n-ethyl methyl-2 pyrrolidino)benzenesulfonamide, procede de preparation et medicaments le contenant
FR2073282A1 (en) 2-phenoxy alkylaminothiazoles - with coronary vasodilator, analgesic, local anaesthetic activity
GB1358979A (en) Treatment of anaplasmosis in cattle
GB947001A (en) Substituted phenoxyalklylguanidines
GB1334815A (en) 2-deoxystrptamine derivatives

Legal Events

Date Code Title Description
ST Notification of lapse